Ian Toma
Overview
Explore the profile of Ian Toma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
424
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaatinen K, Shah P, Mazhari R, Hayden Z, Wargowsky R, Jepson T, et al.
Front Cardiovasc Med
. 2024 Jul;
11:1385457.
PMID: 38978787
Background: Ischemia with non-obstructive coronary arteries (INOCA) is a major clinical entity that involves potentially 20%-30% of patients with chest pain. INOCA is typically attributed either to coronary microvascular disease...
2.
Meltzer A, Wargowsky R, Moran S, Jordan T, Toma I, Jepson T, et al.
Sci Rep
. 2023 Dec;
13(1):21991.
PMID: 38081903
No abstract available.
3.
McCaffrey T, Toma I, Yang Z, Katz R, Reiner J, Mazhari R, et al.
J Mol Cell Cardiol Plus
. 2023 Jun;
4.
PMID: 37303712
Background: Cardiovascular disease had a global prevalence of 523 million cases and 18.6 million deaths in 2019. The current standard for diagnosing coronary artery disease (CAD) is coronary angiography either...
4.
Meltzer A, Wargowsky R, Moran S, Jordan T, Toma I, Jepson T, et al.
Sci Rep
. 2023 Feb;
13(1):2297.
PMID: 36759691
Abdominal pain represents greater than 20% of US Emergency Department (ED) visits due to a wide range of illnesses. There are currently no reliable blood biomarkers to predict serious outcomes...
5.
Wargodsky R, Dela Cruz P, LaFleur J, Yamane D, Kim J, Benjenk I, et al.
PLoS One
. 2022 Jan;
17(1):e0261679.
PMID: 35081105
Infection with the SARS-CoV2 virus can vary from asymptomatic, or flu-like with moderate disease, up to critically severe. Severe disease, termed COVID-19, involves acute respiratory deterioration that is frequently fatal....
6.
St Laurent 3rd G, Toma I, Seilheimer B, Cesnulevicius K, Schultz M, Tackett M, et al.
BMC Genomics
. 2021 Nov;
22(1):854.
PMID: 34823472
Background: Despite proven therapeutic effects in inflammatory conditions, the specific mechanisms of phytochemical therapies are not well understood. The transcriptome effects of Traumeel (Tr14), a multicomponent natural product, and diclofenac,...
7.
McCaffrey T, Toma I, Yang Z, Katz R, Reiner J, Mazhari R, et al.
BMC Med Genomics
. 2021 Sep;
14(1):216.
PMID: 34479557
Background: Cardiovascular disease had a global prevalence of 523 million cases and 18.6 million deaths in 2019. The current standard for diagnosing coronary artery disease (CAD) is coronary angiography. Surprisingly,...
8.
Murakami E, Ghatak-Roy A, Popova M, Gannon C, Park D, Villani J, et al.
Am J Emerg Med
. 2020 Dec;
40:27-31.
PMID: 33340874
The COVID-19 pandemic has spread through the US during the last few months exposing healthcare providers to possible infection. Here we report testing of emergency department (ED) healthcare providers (HCP)...
9.
Mangul S, Martin L, Langmead B, Sanchez-Galan J, Toma I, Hormozdiari F, et al.
Nat Biotechnol
. 2019 Mar;
37(3):324-326.
PMID: 30833765
No abstract available.
10.
Toma I, St Laurent G, McCaffrey T
Per Med
. 2018 May;
8(4):483-491.
PMID: 29783338
The sequencing of the human genome, combined with brilliant technical advances in microarrays and computing, opened the genomic era of personalized medicine. The next generation of genomics is now being...